Search 

Scendea is a leading product development and regulatory consulting practice serving the pharmaceutical and biotechnology industry. We are adept at solving complex issues associated with medicinal product development and offer strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory. Our industry experience is demonstrable, having been involved in over 1,000 development programmes in the US and Europe over the last twenty years. As is our scientific excellence, with a team that includes ex-regulators, high-calibre academics and clinician scientists. Our technical regulatory expertise spans the entire product development spectrum from pre-clinical to marketing authorisation.
Scendea was founded as a result of a management buyout of the product development and regulatory consulting function of a clinical research organisation. Our origin dates back over 20 years, with involvement in over 1,000 development programmes.
Our international team offers strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory, which guide products efficiently from early development to marketing approval. Our scientific excellence, industry experience, commercial awareness and a collaborative approach allow our expert team to solve complex issues associated with medicinal product development.  Scendea has team members based in the UK, Ireland, the Netherlands and the US, who deliver innovative and high-quality solutions aligned to jurisdiction-specific regulatory requirements. At Scendea we collaborate, innovate, and together with our clients, we succeed.